Record ride to raise money, MS awareness
ChronicleHerald.ca - Halifax,Nova Scotia,Canada
He has primary progressive MS, which afflicts just 10 per cent of sufferers. "It's horrible," Alan said. "When I'm struggling, when I'm suffering going up a ...
See all stories on this topic

Acorda Therapeutics Announces Resignation of Mary Fisher
Genetic Engineering News (press release) - New Rochelle,NY,USA
Acorda's lead clinical product, Fampridine-SR, is in a Phase 3 clinical trial to evaluate its safety and efficacy in improving walking ability in people ...
See all stories on this topic

Sunlight in Youth Might Shield Against MS
HealthDay via Yahoo! News Fri, 27 Jul 2007 11:02 AM PDT
FRIDAY, July 27 (HealthDay News) -- A new study of identical twins suggests that children who spend more time in the sun have a lower risk for developing multiple sclerosis (MS) as adults.

FDA hesitant to OK Biogen, Elan drugs
The San Luis Obispo Tribune Fri, 27 Jul 2007 3:52 PM PDT
Federal health officials on Friday said they are hesitant to allow a drug made by Biogen Idec Inc. and Elan Corp. to be used to treat an intestinal disorder because of potentially fatal side effects. The Food and Drug Administration said it is concerned patients taking Tysabri, which is already approved to treat multiple sclerosis, could develop a rare and incurable nervous system disease that is ...